Advertise on podcast: Tales from the Heart

Rating

★★★★★

from

10 reviews

Description

Tales from the Heart is a unique collection of educational, inspirational, and enlightening discussions with the stakeholders in the field of cardiology that come straight from the heart. The guests are patients, physicians, healthcare professionals, industry leaders, state and federal regulators and legislators, journalists, and more. Each story delves into the world of the Hypertrophic Cardiomyopathy Associations network and uncovers the true face of HCM from every angle. Patients will inspire you, medical professionals will educate you, and we may even motivate you to learn more and get involved. In season two Tales welcomes new regular co-host including, Dr. Martin Maron, Dr. Harry Lever, Dr Steve Ommen, Dr. Alex de Feria and more!

Unlock Tales from the Heart podcast Email contact info,
Listeners & Audience details

Email contact information

Direct podcast contact details

Listeners

Audience numbers & engagement insights

Audience details

Podcast Insights

Podcast episodes

Check latest episodes from Tales from the Heart podcast

Getting to the Heart of Diagnosis

2026/10/05

Lisa Salberg welcomes Dr. Sabahat Bokhari to celebrate the launch of a new HCMA Recognized Center of Excellence at Robert Wood Johnson University Hospital. They discuss why accurately diagnosing the cause of a thickened heart matters and how imaging, genetics and a multidisciplinary team can help patients find the right path to personalized care. This conversation was recorded October 2, 2026

A Different Approach to the HCM Heart

2026/10/05

Lisa Salberg talks with Jasmine Patel, Dr. Michael Ayers and Alan Russell of Edgewise Therapeutics about the science behind EDG-7500 and its unique mechanism of action. They break down how this investigational therapy is designed to fine-tune heart contraction and improve relaxation, and what researchers hope it could mean for people with HCM. This conversation was recorded October 1, 2026

When AFib Meets HCM

2026/10/05

Lisa Salberg and Dr. Alex de Feria take a closer look at atrial fibrillation in people with HCM, from recognizing symptoms and reducing stroke risk to medications, cardioversion and newer ablation techniques. They also discuss the rapidly expanding HCM treatment toolbox and why specialized care matters. This conversation was recorded September 24, 2026

A New Era of Hope in HCM

2026/10/05

Lisa Salberg is joined by HCMA Ambassadors Debra Rafson and Joey Graham to explore an exciting new era in HCM, from expanding clinical trials and treatment options to the new Hearts and Minds Mental Health Network. They also share why connection, community and the upcoming HCMA Annual Meeting matter so much to people living with HCM. This conversation was recorded September 18, 2026.

What Longer Monitoring Reveals in HCM

2026/09/16

Lisa Salberg and Dr. Martin Maron explore how extended heart monitoring is uncovering arrhythmias that may go undetected during traditional short-term monitoring. They also discuss A-Fib, today’s options for treating obstruction and emerging research targeting fibrosis in HCM. Conversation recorded Sept. 11, 2026

A New HCM Treatment Takes Shape

2026/09/16

Lisa Salberg and Dr. Anjali Owens break down promising new clinical trial results for EDG-7500, an investigational therapy for both obstructive and nonobstructive HCM. They explain how the drug may improve symptoms and heart relaxation while potentially offering a different safety and monitoring profile from current targeted therapies. Conversation recorded Sept. 4, 2026.

Staying Ahead of AFib in HCM

2026/09/16

Lisa Salberg and Dr. Harry Lever explore atrial fibrillation in HCM, from recognizing risk and monitoring heart rhythms to medications, cardioversion and evolving treatment options. They also discuss generic drug quality, emerging HCM therapies and how decades of progress are giving patients more tools than ever before. Conversation was recorded on Sept. 4, 2026.

A Breakthrough for Nonobstructive HCM

2026/09/01

Live from ESC in Munich, Lisa Salberg and Dr. Martin Maron unpack groundbreaking results from the ACACIA-HCM trial and what they could mean for people with nonobstructive HCM. They discuss improvements in symptoms and exercise capacity, potential changes in heart structure, and a possible path toward a long-awaited new treatment option. Conversation was recorded Aug. 28, 2026

When HCM Symptoms Start to Change

2026/09/01

Lisa Salberg and Dr. Michael Ayres discuss how patients and families can recognize changing HCM symptoms and know when to call their care team or seek urgent help. They also tackle back-to-school planning, beta blockers, cardiac scarring, autonomic symptoms and the changing HCM treatment toolbox. Conversation recorded Aug. 21, 2026

Rethinking Beta Blockers in HCM

2026/09/01

Lisa Salberg and Dr. Martin Maron take a fresh look at the long-standing role of beta blockers in HCM and how newer myosin inhibitors are changing the treatment conversation. They also discuss upcoming clinical data, fibrosis, symptom changes, and how patients can better navigate evolving care. This conversation was recorded Aug. 14, 2026

Expanding the HCM Treatment Toolbox

2026/08/13

Lisa Salberg and Dr. Alex de Feria explore the growing HCM treatment toolbox, including the innovative SESAME procedure, emerging clinical trials and new possibilities for patients. They also tackle back-to-school planning, hydration, exercise, fatigue and helping children navigate life with HCM. This conversation was recorded August 6, 2026.

Targeting Fibrosis: The Next HCM Frontier

2026/08/10

Lisa Salberg and Dr. Martin Maron explore new directions in HCM care, including emerging therapies targeting cardiac fibrosis and what researchers are learning about scarring in the heart. They also look ahead to new clinical trial data and answer patient questions about imaging, arrhythmias and the future of HCM treatment. This conversation was recorded July 24, 2026

The Generic Drug Wake-Up Call

2026/06/30

Lisa Salberg sits down with whistleblower Dinesh Thaker to examine the hidden risks within the generic drug supply chain and why stronger oversight is urgently needed. Together, they discuss drug quality, patient safety, and how advocacy can help drive meaningful change in the healthcare system. This conversation was recorded June 17, 2026.

Summer Strategies for Living Well

2026/06/30

Lisa Salberg and Dr. Steve Ommen discuss practical ways to stay healthy with HCM during the busy summer months. They also break down promising new drug research, explain what emerging biomarkers mean for patients, and share why planning ahead can help people with HCM enjoy life with greater confidence. This conversation was recorded June 19, 2026.

Surgery, Science and HCM Success

2026/06/08

Lisa Salberg sits down with Dr. Nicholas Smedira of the Cleveland Clinic to explore how HCM surgery has evolved over the past three decades. They discuss myectomy, myosin inhibitors, surgical innovation, patient selection, and why experience and high-volume centers continue to matter in achieving the best outcomes for patients. This conversation was recorded June 8, 2026.